Febrile neutropenia (FN) is a serious, sometimes life-threatening complication of cancer chemotherapy. Episodes of FN are associated with substantial morbidity, mortality, and cost as well as dose reductions and treatment delays that may compromise the delivery of full dose chemotherapy. Proper prophylaxis and a prompt, comprehensive treatment approach are essential to successful management of FN. Recent research has resulted in increased insight and understanding of as well as the development of new agents (such as G-CSF) for FN. Part of the Oxford American Pocket Cards series, this concise, ultra-portable, up-to-date and attractively designed medical reference card provides essential clinical tools to aid the busy clinician in the diagnosis and treatment of febrile neutropenia at the point of care.